|
|||||
|
|
Verteporfin inhibits the persistent fibrotic phenotype of lesional scleroderma dermal fibroblasts |
|
| Authors: | Xu Shi-wen Michael Racanelli Aaisham Ali Amara Simon Katherine Quesnel Richard J Stratton Andrew Leask |
| Institution: | 1.UCL Division of Medicine, Centre for Rheumatology, University College London, Royal Free Campus, Rowland Hill St, London, NW3 2PF UK ;2.Department of Physiology and Pharmacology, University of Western Ontario, London, ON N6A 5C1 Canada ;3.School of Dentistry, University of Western Ontario, London, ON N6A 5C1 Canada ;4.College of Dentistry, University of Saskatchewan, 105 Wiggins Rd, Saskatoon, SK S7N 5E4 Canada |
| Abstract: | |
| Keywords: | YAP1 Scleroderma Verteporfin CCN2 Connective tissue growth factor CTGF Fibrosis Mechanotransduction Myofibroblasr |